AtCor Medical is a leader in developing and marketing cardiovascular technologies for risk assessment and patient management.

ATCOR MEDICAL INVESTOR

NEW Analysts' Reports
Taylor Collison Sharebrokers and Investment Advisers have initiated coverage of AtCor Medical Holdings Limited.

Please click here to view their reports.

Newsletter
Welcome to the first edition of our new investor newsletter. Our objective is to keep you informed of the key initiatives and programs that will drive the growth and progress of your company around the world.

Please click here to view the Investor Newsletter.

 VIEW PRODUCT DEMONSTRATION

The SphygmoCor system provides a quick and non-invasive method of obtaining key cardiovascular data thereby enhancing the treatment and management of patients.

Click below to view a brief demonstration of the steps involved in taking a SphygmoCor measurement. 

Click here for demonstration

 NEWS

13 November 2008 : NIH Study Supports Central Blood Pressure as a Treatment Target

12 November 2008 : Superior Predictor of Development of Atrial Fibrillation

05 November 2008 : AtCor Medical Anticipates Continued Strong Growth in FY2009

03 November 2008 : US $0.5m New Pharmaceutical Trial Contract

31 October 2008 : AtCor to Target Specialists with Lightweight SphygmoCor